Chromosome-packing blockers for bacterial eye infections
Official title: Chromosome Packing Inhibitors for the Treatment of Eye Infections
Funded at University of Oklahoma · NIH-11171393 · Data updated 2026-11-12
This project explores a new type of antibiotic that blocks how bacteria pack their DNA to help people with bacterial eye infections, such as those after surgery or from contact lenses.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $226,825 |
| NIH project number | 5R21EY036599-02 |
| Project ID | NIH-11171393 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with bacterial eye infections, especially bacterial keratitis after eye surgery or contact lens use, would be the likely candidates for future clinical testing of this approach.
✕Less likely to help
Patients with viral, fungal, allergic, or other non-bacterial eye conditions would not be expected to benefit from this bacterial-targeted therapy.
What this research studies
Researchers are developing drugs called condensin inhibitors that disrupt how bacteria organize their chromosomes, which is important for their ability to cause disease. They will study how blocking condensins changes the way Pseudomonas aeruginosa interacts with the eye and host defenses. The team will test a lead condensin inhibitor in a live model of bacterial keratitis to see if it can reduce infection and damage. The goal is to find a new antibiotic mechanism that could work against drug-resistant eye infections and protect vision.
Why it matters
Potential benefit: If successful, this could lead to a new antibiotic option that works against resistant bacteria and helps prevent vision loss from bacterial eye infections.
How similar studies have gone: This approach is largely novel — targeting bacterial condensins is a new mechanism that has not yet been tested in human eye infections, though other novel antibiotics have sometimes helped resistant infections.
Where this research is happening
-
University of Oklahoma
Norman, United States Active
Researchers
- Principal investigator: Rybenkov, Valentin V — University of Oklahoma
- Study coordinator: Rybenkov, Valentin V
Related research
Other NIH-funded projects on the same topics.
-
Personalized 3D molds to shape breast reconstruction
A doctor-relevant project is testing patient-specific 3D printed molds to guide breast reconstruction after mastectomy, aiming to improve body image and quality of life for feminine-presenting individuals.
-
Faster 3D/4D imaging to speed up testing of cancer drugs on tumor organoids
This project builds a new, ultrafast label-free 4D imaging system with AI to watch how patient-like tumor organoids respond to cancer drugs, helping researchers find more promising treatments.
-
How our genes control skin color and pigmentation
Scientists are studying how epigenetic and transcriptional controls shape human skin color and related pigmentation differences.
-
Nanomedicine delivery framework for skeletal muscle therapies
A new framework aims to safely and efficiently deliver tiny nanoparticles carrying drugs or genetic payloads to skeletal muscle cells.
-
Atlas of bacterial drug entry and exit to help design better antibiotics
Researchers are building smart computer models and chemical tests to understand how to get drugs into Gram-negative bacteria like Acinetobacter baumannii so new antibiotics can work.
-
Understanding protein forms in disease with advanced mass spectrometry
A researchers team will use a cutting-edge mass spectrometry approach to map and measure the full shape and connections of disease-related proteins in human biology.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.